What are the first-line antibiotics for suspected cellulitis in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

First-Line Antibiotics for Suspected Cellulitis

For nonpurulent cellulitis (the most common presentation), start with a beta-lactam antibiotic targeting beta-hemolytic streptococci—specifically cephalexin 500 mg four times daily or dicloxacillin 500 mg four times daily for 5-10 days. 1

Clinical Decision Algorithm

Step 1: Classify the Cellulitis Type

Nonpurulent cellulitis (no drainage, no exudate, no abscess):

  • First-line: Beta-lactam antibiotics targeting streptococci 1, 2

    • Cephalexin 500 mg PO four times daily (preferred for convenience) 3, 4
    • Dicloxacillin 500 mg PO four times daily (alternative) 3, 4
    • Cefazolin 1 g IV every 8 hours (if hospitalized) 3, 4
  • Duration: 5-10 days based on clinical response 1

Purulent cellulitis (drainage or exudate present, no drainable abscess):

  • First-line: Cover CA-MRSA empirically 1
    • Clindamycin 300-450 mg PO three times daily (covers both streptococci and MRSA) 1
    • TMP-SMX 1-2 double-strength tablets twice daily PLUS amoxicillin (if dual coverage needed) 1
    • Doxycycline 100 mg twice daily PLUS amoxicillin (alternative combination) 1

Step 2: Assess for Treatment Failure Indicators

Add MRSA coverage if:

  • No response to beta-lactam therapy after 48-72 hours 1, 2
  • Systemic toxicity present (fever, tachycardia, hypotension) 1
  • Severe infection requiring hospitalization 1

Step 3: Hospitalized/Complicated Cases

For hospitalized patients with complicated SSTI (deeper infections, major wounds, systemic illness):

  • IV vancomycin 30 mg/kg/day in 2 divided doses (first choice) 1, 2
  • Linezolid 600 mg IV/PO twice daily (alternative) 1
  • Daptomycin 4 mg/kg IV once daily (alternative) 1
  • Duration: 7-14 days based on response 1

Key Evidence and Rationale

The IDSA guidelines 1, 2 consistently emphasize that nonpurulent cellulitis is primarily caused by beta-hemolytic streptococci, NOT MRSA. This is critical because many clinicians over-treat with MRSA coverage unnecessarily. The guidelines explicitly state that "empirical therapy for infection due to β-hemolytic streptococci is recommended" and that "the role of CA-MRSA is unknown" in nonpurulent cellulitis 1.

Clindamycin receives the highest evidence grade (A-I) among oral options when MRSA coverage is needed 1, making it the preferred single agent when dual coverage is desired since it covers both streptococci and MRSA 1.

Critical Pitfalls to Avoid

  1. Don't automatically cover MRSA for simple nonpurulent cellulitis - This is the most common error. Reserve MRSA coverage for purulent infections or treatment failures 1, 5.

  2. Bilateral cellulitis is rare - Consider alternative diagnoses like venous stasis dermatitis, which doesn't require antibiotics 6, 5.

  3. Check local clindamycin resistance rates - If erythromycin resistance exceeds 10%, clindamycin may have inducible resistance and should be avoided 1.

  4. Don't use TMP-SMX alone for nonpurulent cellulitis - It lacks adequate streptococcal coverage and must be combined with a beta-lactam 1.

  5. Avoid rifampin - It should not be used as monotherapy or adjunctive therapy for cellulitis 1.

Special Populations

Children:

  • Same antibiotics at weight-based dosing: cephalexin 25-50 mg/kg/day in 3-4 divided doses 3, 4
  • Avoid tetracyclines under age 8 1, 2, 1
  • For hospitalized children with complicated SSTI: vancomycin 40 mg/kg/day in 4 divided doses 1

Pregnancy:

  • Beta-lactams (cephalexin, amoxicillin) are safe
  • Avoid TMP-SMX in third trimester 1

Related Questions

What oral and intravenous antibiotics should I order for a patient with cellulitis of the skin?
What is the appropriate management for traumatic cellulitis, including antibiotic selection, dosing, and supportive care?
What is the first‑line antibiotic for cellulitis of the mons pubis in a patient without β‑lactam allergy or MRSA risk?
What are the recommended treatment guidelines for cellulitis of the chin?
What is the recommended antibiotic regimen for an adult with uncomplicated cellulitis of the abdominal wall without an abscess?
What is the most likely cause of a child's perianal itching with passage of rice‑like particles: Strongyloides infection, Enterobius vermicularis (pinworm), Ascaris, or Ameba?
What empiric antibiotic regimen should be used for culture-negative infective endocarditis in a patient with an ampicillin allergy?
What is the recommended Augmentin (amoxicillin/clavulanate) dosing for upper respiratory infection and acute otitis media in adults and children?
What is the recommended treatment for a 35‑year‑old with a five‑month history of alternating constipation and diarrhea, mucus in the stool, and abdominal cramping, likely secondary to migraine medication (mixed‑type irritable bowel syndrome)?
Can I use ceftriaxone in a patient with a mild ampicillin allergy for culture‑negative infective endocarditis, and what is the recommended treatment duration for native versus prosthetic valves?
What chemoprophylaxis regimen is appropriate for the asymptomatic household contacts of a pediatric patient diagnosed with meningococcal meningitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.